| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/09/2007 | CN1314705C Peptide for high performance inhibition of angiogenesis and method for preparing same and use thereof |
| 05/09/2007 | CN1314704C Oligopeptide suppressor of matrix metalloprotease 2 |
| 05/09/2007 | CN1314698C Micromolecule interference RNA aiming at middle period factor gene and use thereof |
| 05/09/2007 | CN1314696C 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 05/09/2007 | CN1314679C Compound of substituted nonane oxide-2-ketone, preparation method and application |
| 05/09/2007 | CN1314675C Taxol derivatives |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314670C Piperidine nitroxide free-radical derivative and its use |
| 05/09/2007 | CN1314424C Chinese traditional medicine for treating liver cancer and preparation technique thereof |
| 05/09/2007 | CN1314409C Medicine for inhibiting and eliminating cancer |
| 05/09/2007 | CN1314394C Pharmaceutical composition containing double nucleus platinum complex and its application in anti-tumour |
| 05/09/2007 | CN1314386C Tripterygium hypoglaucum contained transdermal plaster and its preparation |
| 05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214794 Capable of crossing cell membrane; induction apoptosis in human cancer cells |
| 05/08/2007 | US7214790 Genes and proteins encoded thereby |
| 05/08/2007 | US7214782 Prognosis of neuroblastoma; antisense nucleic acids for malignant tumors |
| 05/08/2007 | US7214772 Sialoadhesin family member-2 (SAF-2) |
| 05/08/2007 | US7214771 Nucleic acid and protein expression thereby and their involvement in stress |
| 05/08/2007 | US7214716 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives |
| 05/08/2007 | US7214713 Supplement with anticancer properties with fermentation of carbohydrates with biosynthesis of Penicillum |
| 05/08/2007 | US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214706 Osteoporosis, postmenopause |
| 05/08/2007 | US7214705 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein |
| 05/08/2007 | US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer |
| 05/08/2007 | US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers |
| 05/08/2007 | US7214689 Isoquinoline compounds |
| 05/08/2007 | US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214670 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 |
| 05/08/2007 | US7214669 Tetracycline derivatives and methods of use thereof |
| 05/08/2007 | US7214668 Viricides; anticancer agents; liver disorders |
| 05/08/2007 | US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a |
| 05/08/2007 | US7214533 Polynucleotide useful for modulating cancer cell proliferation |
| 05/08/2007 | US7214518 For therapy of diseases of cell proliferation |
| 05/08/2007 | US7214495 Screening method |
| 05/08/2007 | US7214493 For therapy of cancer |
| 05/08/2007 | US7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene |
| 05/08/2007 | CA2373990C Pyrrolotriazine inhibitors of kinases |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2310593C Metalloproteinase inhibitors |
| 05/08/2007 | CA2267498C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 05/08/2007 | CA2228492C Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 05/08/2007 | CA2185489C Cyclic adhesion inhibitors |
| 05/08/2007 | CA2182878C Novel cytotoxic macrolides and methods of use |
| 05/03/2007 | WO2007051119A1 Methods and compositions of parp inhibitors as potentiators in cancer therapy |
| 05/03/2007 | WO2007050784A2 Fixed ratio drug combination treatments for solid tumors |
| 05/03/2007 | WO2007049846A1 Process for preparation of rhus verniciflua extracts having excellent anti-cancer activity and anti-cancer pharmaceutical composition containing the same |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049708A1 Ultrasonic cancer therapy accelerator and cytotoxic agent |
| 05/03/2007 | WO2007049624A1 Preventives/remedies for cancer |
| 05/03/2007 | WO2007049620A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 05/03/2007 | WO2007049575A1 Taxane compound with azetidine ring structure |
| 05/03/2007 | WO2007049542A1 METHOD FOR PREDICTION OF EFFECTIVENESS OF RAR-α AGONIST |
| 05/03/2007 | WO2007049424A1 Hepatic fibrosis inhibitor |
| 05/03/2007 | WO2007049409A1 Recombinant hsv useful for treatment of human glioma |
| 05/03/2007 | WO2007049041A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 05/03/2007 | WO2007048918A1 Novel esterified amino compounds having a hydrocarbon ring e with six camptothecin analogue ring members, preparation method thereof and pharmaceutical compositions containing same |
| 05/03/2007 | WO2007048917A1 Novel esterified amino compounds having a hydrocarbon ring e with seven camptothecin-derived ring members, preparation method thereof and pharmaceutical compositions containing same |
| 05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | WO2007048767A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | WO2007048326A1 Nanometer targeted drug for magneto-thermotherapy of malignant tumors |
| 05/03/2007 | WO2007048224A1 Iap bir domain binding compounds |
| 05/03/2007 | WO2007032936A3 Azafused cyclin dependent kinase inhibitors |
| 05/03/2007 | WO2007029251A3 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase |
| 05/03/2007 | WO2007027855A3 Raf inhibitor compounds and methods of use thereof |
| 05/03/2007 | WO2007027528A3 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 05/03/2007 | WO2007026190A3 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| 05/03/2007 | WO2007026041A3 Compuestos quinónicos antitumorales y sus derivados, procedimiento de obtención y sus aplicaciones |
| 05/03/2007 | WO2007011626A3 Histone deacetylase inhibitors |
| 05/03/2007 | WO2007010013A3 Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases |
| 05/03/2007 | WO2007009120A3 Heterotetracyclic compounds as tpo mimetics |
| 05/03/2007 | WO2007009007A3 Methods of treatment using hydroquinone ansamycins |
| 05/03/2007 | WO2006133147A3 Organic compounds |
| 05/03/2007 | WO2006099875A8 Antibodies against cd38 for treatment of multiple myeloma |
| 05/03/2007 | WO2006024770A8 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 05/03/2007 | WO2005075418A3 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070100561 Crystals of DPP-IV |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099977 Conjugated psychotropic drugs and uses thereof |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099906 Combinations for the treatment of noeplastic disorders |
| 05/03/2007 | US20070099905 Combinations of drugs for the treatment of neoplasms |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099876 Target directed chemotherapy of tumours of the sexual organs |
| 05/03/2007 | US20070099874 Methods and compositions of novel triazine compounds |
| 05/03/2007 | US20070099870 Lipid analogs for combating tumors |
| 05/03/2007 | US20070099866 Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate |
| 05/03/2007 | US20070099253 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 05/03/2007 | US20070098816 Pharmaceutical composition containing histone deacetylase inhibitor |
| 05/03/2007 | US20070098808 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| 05/03/2007 | US20070098760 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 05/03/2007 | US20070098757 E-PTFE foil impregnated with an encapsulated bioactive substance |